CRAC intermediate 1

• Description :

  CRAC intermediate 1 is a key intermediate in the chemical synthesis of a series of CRAC channel inhibitors, detailed information can be found in Patent WO 2010122089 A1, intermediate 9.

• UNSPSC :

  12352005

• Hazard Statement :

  H302, H315, H319, H335

• Target :

  CRAC Channel

• Type :

  Reference compound

• Related Pathways :

  Membrane Transporter/Ion Channel

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/CRAC-intermediate-1.html

• Concentration :

  10mM

• Purity :

  98.46

• Solubility :

  DMSO : ≥ 50 mg/mL

• Smiles :

  O=C(C1=C(F)C=CC=C1F)NC2=NNC=C2

• Molecular Formula :

  C10H7F2N3O

• Molecular Weight :

  223.18

• Precautions :

  H302, H315, H319, H335

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [1249343-86-9]